DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1Biophore India Pharmaceuticals Pvt Ltd
03 1Chunghwa Chemical Synthesis & Biotech
04 1TAPI Technology & API Services
05 1Allite (Shanghai) Pharmaceutical Technology
06 1Chongqing Carelife Pharmaceutical
07 1Chongqing Pharmaceutical Research Institute Co Ltd
08 1Fresenius Kabi Oncology Limited
09 1Intas Pharmaceuticals
10 1Laurus Labs
11 1Lunan Pharmaceutical
12 1MSN Laboratories
13 1Polymed Therapeutics Inc.
14 1Qilu Pharmaceutical
15 1SEACROSS PHARMACEUTICALS
01 10CARFILZOMIB
02 1CARFILZOMIB (NON-STERILE BULK DRUG SUBSTANCE)
03 1CARFILZOMIB (NON-STERILE, API)
04 1CARFILZOMIB DRUG SUBSTANCE
05 1CARFILZOMIB NON-STERILE BULK DRUG SUBSTANCE
06 1CARFILZOMIB [ROUTE CODE "CJ"]
01 5China
02 6India
03 1Israel
04 1Taiwan
05 1U.S.A
06 1United Kingdom
01 12Active
02 3Inactive
01 10Complete
02 5Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2016-07-06
Pay. Date : 2016-05-04
DMF Number : 30402
Submission : 2016-03-29
Status : Active
Type : II
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Complete
Rev. Date : 2024-09-19
Pay. Date : 2024-08-27
DMF Number : 32406
Submission : 2017-12-30
Status : Active
Type : II
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31276
Submission : 2016-12-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-02-25
Pay. Date : 2015-12-21
DMF Number : 30124
Submission : 2016-01-21
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-07-03
Pay. Date : 2023-05-18
DMF Number : 38180
Submission : 2023-05-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-10-09
Pay. Date : 2020-09-01
DMF Number : 35083
Submission : 2020-09-08
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-04-19
Pay. Date : 2016-01-20
DMF Number : 30115
Submission : 2016-03-22
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-11-16
Pay. Date : 2015-09-23
DMF Number : 29671
Submission : 2015-08-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30357
Submission : 2016-02-26
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-02-05
Pay. Date : 2015-09-25
DMF Number : 29770
Submission : 2015-09-28
Status : Active
Type : II
A Carfilzomib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carfilzomib, including repackagers and relabelers. The FDA regulates Carfilzomib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carfilzomib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Carfilzomib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Carfilzomib supplier is an individual or a company that provides Carfilzomib active pharmaceutical ingredient (API) or Carfilzomib finished formulations upon request. The Carfilzomib suppliers may include Carfilzomib API manufacturers, exporters, distributors and traders.
click here to find a list of Carfilzomib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Carfilzomib DMF (Drug Master File) is a document detailing the whole manufacturing process of Carfilzomib active pharmaceutical ingredient (API) in detail. Different forms of Carfilzomib DMFs exist exist since differing nations have different regulations, such as Carfilzomib USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Carfilzomib DMF submitted to regulatory agencies in the US is known as a USDMF. Carfilzomib USDMF includes data on Carfilzomib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Carfilzomib USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Carfilzomib suppliers with USDMF on PharmaCompass.
We have 15 companies offering Carfilzomib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?